Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Tue, 11.03.2025
Semperit AG Holding
Semperit AG Holding: Earnings forecast for first quarter of 2025 well below previous year’s figures; operating EBITDA expected in the range of EUR 70 million to EUR 90 million in 2025
Vienna, March 11, 2025 – Based on the earnings forecast for the first quarter of 2025, Semperit AG Holding expects EBITDA to decline by around 50% compared with th [ … ]
Tue, 11.03.2025
Gigaset AG
Ad hoc announcement
WKN: 515600 / WKN A14KQ7
Gigaset AG i.L.: Conditions of the insolvency plan not fully met
Bocholt, 11 March 2025 [18:45 CET] – The insolvency administrator has informed the Management Board today that the conditions set out in the insolvency plan for Gigaset AG i.L., which was submitted by the insolvency administrator and una [ … ]
Tue, 11.03.2025
PUMA SE
Disclosure of inside information according to Article 17 Market Abuse Regulation
PUMA SE (ISIN: DE00069696303 WKN: 696960)
PUMA WAY 1, D-91074 Herzogenaurach
PUMA announces its Outlook for 2025
Herzogenaurach, Germany, 11 March 2025 – Sports company PUMA announces its outlook for the financial year 2025.
PUMA a [ … ]
Tue, 11.03.2025
STRABAG SE
After expiration of deadline: further negotiations of transaction to acquire parts of VAMED Group
Closing conditions of purchase agreement remain unfulfilled at contractually agreed date
Negotiation of key points of transaction by STRABAG/PORR being continued
The purchase agreement for the acquisition of parts of VAMED Group, concluded in May 202 [ … ]
Tue, 11.03.2025
Lenzing AG
Lenzing AG: Changes to the Supervisory Board
Lenzing – The Chairman of the Supervisory Board of Lenzing AG, Cord Prinzhorn, has informed the Nomination Committee of the Supervisory Board today that he will not extend his term as a member of the company's Supervisory Board after the Annual General Meeting on April 17, 2025 and will not stand fo [ … ]
Tue, 11.03.2025
KOMAX Holding AG
Dierikon, 11 March 2025
Media releaseAd hoc announcement pursuant to Art. 53 LR
2024 annual financial statements of the Komax Group
The Komax Group looks back on an extremely challenging year. Customers invested less due to excess capacities as well as geopolitical uncertainties, and this led to a significant decline in order intake (–15.9%), rev [ … ]
Tue, 11.03.2025
Orascom Development Holding AG
Ad hoc announcement pursuant to Art. 53 LR.
Orascom Development Holding AG announces its Egyptian Subsidiary (ODE) FY 2024 Financial Results.
Altdorf, 11 March 2025 – Orascom Development Holding AG (ODH) is pleased to announce that Orascom Development Egypt (ODE), the largest Egyptian subsidiary of the Group, has reported its FY 2024 financial r [ … ]
Tue, 11.03.2025
Partners Group
Baar-Zug, Switzerland; 11 March 2025 | Ad hoc announcement pursuant to Art. 53 Listing Rules (LR)
Revenues increased by 10% to CHF 2’136 million
Management fees amounted to CHF 1’625 million, up 3%, adversely impacted by FX effects
Performance fees up 38% to CHF 511 million (24% of total revenues); improved exit activity drove H2 results; forwa [ … ]
Tue, 11.03.2025
Henkel AG & Co. KGaA
Düsseldorf, 2025-03-11T06:22+01:00 (CET)
Henkel decides on new share buyback program with a volume of up to 1 billion euros
Düsseldorf – The Management Board of Henkel AG & Co. KGaA resolved at its meeting today, with the approval of the Shareholders' Committee, to launch a share buyback program with a total value of up to 1 billion euros. H [ … ]
Tue, 11.03.2025
PolyPeptide Group
Media release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide with substantial improvements in profitability and cash flow, positioned for strong growth
Baar, 11 March 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced its annual results for 2024 and gu [ … ]
